Icon

REGLAN ODT (nda021793)- (EQ 5MG BASE,EQ 10MG BASE)

METOCLOPRAMIDE HYDROCHLORIDE MEDA PHARMS
EQ 5MG BASE,EQ 10MG BASE
No No
2018-Apr-09 Expired
None None
None No
REGLAN ODT™ is a dopamine receptor antagonist indicated for:  Symptomatic Gastroesophageal Reflux: Short-term (4 to 12 weeks) therapy for adults with symptomatic, documented gastroesophageal reflux(GERD) who fail to respond to conventional therapy.  Diabetic Gastroparesis (Diabetic Gastric Stasis): The relief of symptoms associated with acute and recurrent diabetic gastric stasis.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 5MG BASE ** ** - - -
EQ 10MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.